Location History:
- Bishops Stortford, GB (2008)
- Newton, MA (US) (2012 - 2013)
Company Filing History:
3 out of 2,405 
1 out of 76 Years Active: 2008-2013
Title: Innovator Mark Steven Shearman: Pioneering Cancer Treatment Solutions
Introduction
Mark Steven Shearman, based in Newton, MA, is a distinguished inventor known for his significant contributions to cancer treatment through innovative pharmaceuticals. With a total of three patents to his name, Shearman's work reflects a robust dedication to enhancing healthcare options for patients battling cancer.
Latest Patents
Among his recent patents, Shearman has developed formulations that reveal promising new avenues for cancer treatment. His notable patents include:
1. **Cyclohexyl Sulphones for Treatment of Cancer** - This patent details the use of sulphones of formula (I) for effective cancer treatment.
2. **Bridged Bicyclic Sulphamides for Treatment of Cancer** - This innovation introduces bridged bicyclic sulphamides of formula (I) aimed at combating cancer.
Career Highlights
Throughout his career, Shearman has worked with renowned organizations, including Merck Sharp & Dohme Corporation and Merck Frosst Canada & Co. His experience in these leading pharmaceutical companies has equipped him with the knowledge and expertise to develop impactful medical solutions.
Collaborations
Shearman has collaborated with notable professionals in the field, including his coworkers Timothy Harrison and Huw David Lewis. These partnerships highlight the cohesive efforts often required to inspire innovation and drive research towards practical healthcare solutions.
Conclusion
Mark Steven Shearman's inventive spirit and dedication to research exemplify the pivotal role inventors play in the fight against cancer. As the healthcare industry continues to evolve, his contributions will likely have lasting impacts on treatment methodologies and patient care.